The Pharmacoepidemiology of Selective Serotonin Reuptake Inhibitors for Children and Adolescents in Canada from 2005 to 2009: A Database Analysis

被引：0
|
作者：
Darren Lam
Daniel A. Gorman
Scott Patten
Tamara Pringsheim
机构：
[1] University of Calgary,Department of Clinical Neurosciences Psychiatry, and Pediatrics
[2] C4-431,Department of Psychiatry
[3] Alberta Children’s Hospital,Department of Community Health Sciences and Psychiatry
[4] University of Toronto,undefined
[5] University of Calgary,undefined
来源：
Pediatric Drugs | 2013年 / 15卷
关键词：
Major Depressive Disorder; Fluoxetine; Paroxetine; Escitalopram; Canadian Youth;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：319 / 327
页数：8
相关论文
共 50 条
  • [41] Efficacy of selective serotonin reuptake inhibitor treatment in children and adolescents
    Bailly, Daniel
    PRESSE MEDICALE, 2006, 35 (09): : 1293 - 1302
  • [42] Selective serotonin reuptake inhibitors in the context of an ongoing analysis
    Gabbard, GO
    Bartlett, AB
    PSYCHOANALYTIC INQUIRY, 1998, 18 (05) : 657 - 672
  • [43] The selective serotonin reuptake inhibitors controversy in the treatment of depression in children
    Weller E.B.
    Tucker S.
    Weller R.A.
    Current Psychiatry Reports, 2005, 7 (2) : 87 - 90
  • [44] Selective serotonin reuptake inhibitors and type 2 diabetes in adolescents and youths
    Sun, Jenny W.
    Bateman, Brian T.
    Hernandez-Diaz, Sonia
    Haneuse, Sebastien
    Bourgeois, Florence T.
    Huybrechts, Krista F.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 447 - 447
  • [45] Body Composition in Adolescents During Treatment With Selective Serotonin Reuptake Inhibitors
    Calarge, Chadi A.
    Mills, James A.
    Janz, Kathleen F.
    Burns, Trudy L.
    Coryell, William H.
    Zemel, Babette S.
    PEDIATRICS, 2017, 140 (01)
  • [46] Treatment-emergent adverse events from selective serotonin reuptake inhibitors by age group: Children versus adolescents
    Safer, DJ
    Zito, JM
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2006, 16 (1-2) : 159 - 169
  • [47] Treatment of major depressive disorder in children and adolescents - Most selective serotonin reuptake inhibitors are no longer recommended
    Ramchandani, P
    BRITISH MEDICAL JOURNAL, 2004, 328 (7430): : 3 - 4
  • [48] Clinician compliance to recommendations regarding the risk of suicidality with selective serotonin reuptake inhibitors in the treatment of children and adolescents
    Johanne Østerby Sørensen
    Annette Rasmussen
    Troels Roesbjerg
    Anne Katrine Pagsberg
    European Child & Adolescent Psychiatry, 2020, 29 : 707 - 718
  • [49] Clinician compliance to recommendations regarding the risk of suicidality with selective serotonin reuptake inhibitors in the treatment of children and adolescents
    Sorensen, Johanne Osterby
    Rasmussen, Annette
    Roesbjerg, Troels
    Pagsberg, Anne Katrine
    EUROPEAN CHILD & ADOLESCENT PSYCHIATRY, 2020, 29 (05) : 707 - 718
  • [50] Combination treatment with clomipramine and selective serotonin reuptake inhibitors for obsessive-compulsive disorder in children and adolescents
    Figueroa, Y
    Rosenberg, DR
    Birmaher, B
    Keshavan, MS
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 1998, 8 (01) : 61 - 67
12345